Kenvue is expected to announce its third-quarter results by early November, and analysts expect a notable decline in earnings ...

For over a decade, and as recently as August, FDA has fully evaluated the emerging scientific evidence and repeatedly ...

“For over a decade — and as recently as August — FDA has fully evaluated the emerging scientific evidence and repeatedly ...

Starboard Value CEO Jeff Smith said that he is "thrilled to own" Kenvue (NYSE:KVUE) even though the stock is down ~30% year ...

After popular pain med Tylenol came under fire from officials in the Trump administration for an alleged link to autism if ...

Kenvue urged U.S. regulators to deny a request warning against Tylenol’s use during pregnancy, laying out the most detailed ...

Explore Kenvue Inc. (NYSE:KVUE) trends, dividends, and market activity among consumer stocks in S&P 500 today.

On Oct. 17, Kenvue filed a response to the Citizen Petition, arguing against the need to add a pregnancy/autism risk warning ...

I would like to receive updates and special offers from Dow Jones and affiliates. I can unsubscribe at any time.

Shares of Tylenol maker Kenvue dropped Monday ahead of an anticipated announcement by the Trump administration linking pregnant women’s use of the painkiller to autism.

Kenvue has urged U.S. regulators to reject a request seeking autism warning label on its popular over-the-counter pain ...

Kenvue, Tylenol manufacturer, has asked US regulators to reject a request for an autism warning label on Tylenol when used ...